Covid 19

Posted on September 7, 2021, updated on September 16, 2021 by Director

CORONAVIRUS RESOURCE CENTER

CDC

CDC Strengthens Recommendations and Expands Eligibility for COVID-19 Booster Shots
Following today’s meeting of the Advisory Committee on Immunization Practices’ (ACIP), CDC is expanding eligibility of COVID-19 vaccine booster doses to everyone 5 years of age and older.
CDC and Health Partners Responding to Monkeypox Case in the U.S.
Case identified after monkeypox clusters in several other countries
Update on Children with Acute Hepatitis of Unknown Cause
The Centers for Disease Control and Prevention (CDC) continues to work with health departments and clinicians nationwide to identify and investigate hepatitis of unknown cause impacting children.
Firearm Deaths Grow, Disparities Widen
Firearms were involved in 79% of all homicides and 53% of all suicides in 2020.
CDC Media Briefing — New <em>Vital Signs</em> Report Firearm deaths show historic increase What can be done to prevent firearm homicides and suicides?
Against the backdrop of the COVID-19 pandemic, there has been a 35% increase in the firearm homicide rate, with the rate in 2020 reaching its highest level in over 25 years, according to a new CDC Vital Signs report.
CDC Media Telebriefing: Update on Acute Hepatitis of Unknown Cause
Experts from the Centers for Disease Control and Prevention will discuss the latest regarding the cases of acute hepatitis of unknown cause.
CDC Recommendation for Masks and Travel
At this time, CDC recommends that everyone aged 2 and older – including passengers and workers – properly wear a well-fitting mask or respirator over the nose and mouth in indoor areas of public transportation (such as airplanes, trains, etc.) and transportation hubs (such as airports, stations, etc.).
Proactive Statement: MMWR on children with acute hepatitis and adenovirus infection in Alabama
A new study published by the Centers for Disease Control and Prevention (CDC) today, “Acute Hepatitis and Adenovirus Infection Among Children — Alabama, October 2021–February 2022” provides additional clinical and epidemiologic information from an ongoing investigation involving children in Alabama with hepatitis (inflammation of the liver) of unknown cause.
U.S. Case of Human Avian Influenza A(H5) Virus Reported
A person has tested positive for avian influenza A(H5) virus (H5 bird flu) in the U.S., as reported by Colorado and confirmed by CDC.
CDC’s Annual Gathering of Disease Detectives Showcases Findings from the Front Lines of Public Health
CDC will hold its annual Epidemic Intelligence Service (EIS) Conference May 2-5, 2022, via a virtual platform that is free and open to the public. This conference highlights CDC’s disease detectives’ outbreak investigations, innovative analyses, and unity in service.
Transcript for CDC Media Telebriefing: Update on COVID-19
CDC works 24/7 saving lives, protecting people from health threats, and saving money to have a more secure nation. A US federal agency, CDC helps make the healthy choice the easy choice by putting science and prevention into action. CDC works to help people live longer, healthier and more productive lives.
CDC Press Release: Hypertensive disorders in pregnancy affect 1 in 7 hospital deliveries
The prevalence of hypertensive disorders in pregnancy (HDP) among delivery hospitalizations increased from about 13% in 2017 to 16% in 2019, affecting at least 1 in 7 delivery hospitalizations during this period, according to a CDC report.
CDC Media Telebriefing: Update on COVID-19
The Centers for Disease Control and Prevention will provide an update to media on the COVID-19 pandemic.
COVID-19 Was Third Leading Cause of Death in U.S.
Two reports released in today’s MMWR use CDC’s National Vital Statistics System to look at death rates in the United States and find that differences in death rates still remain between certain racial and ethnic minority groups.
CDC Alerts Providers to Hepatitis Cases of Unknown Origin
CDC today issued a nationwide health alert to notify clinicians and public health authorities about a cluster of children identified with hepatitis and adenovirus infection – and to ask all physicians to be on the lookout for symptoms and to report any suspected cases of hepatitis of unknown origin to their local and state health […]
CDC Media Telebriefing: Vaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten — United States, 2020–21 School Year
Experts from the Centers for Disease Control and Prevention will discuss Thursday’s MMWR, “Vaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten — United States, 2020–21 School Year.” Information presented in the telebriefing is embargoed until Thursday, April 21 at 1pm ET.
CDC Statement on Masks in Public Transportation Settings
To protect CDC’s public health authority beyond the ongoing assessment announced last week, CDC has asked DOJ to proceed with an appeal in Health Freedom Defense Fund, Inc., et al., v. Biden, et al.
CDC Launches New Center for Forecasting and Outbreak Analytics
Today, the Centers for Disease Control and Prevention (CDC) announced the launch of the Center for Forecasting and Outbreak Analytics (CFA). CFA seeks to enhance the nation’s ability to use data, models, and analytics to enable timely, effective decision-making in response to public health threats for CDC and its public health partners.
CDC Mask Order Remains in Effect and CDC Realigns Travel Health Notice System
CDC works 24/7 saving lives, protecting people from health threats, and saving money to have a more secure nation. A US federal agency, CDC helps make the healthy choice the easy choice by putting science and prevention into action. CDC works to help people live longer, healthier and more productive lives.
New data suggest STDs continued to increase during first year of the COVID-19 pandemic
Reported cases of sexually transmitted diseases (STDs) in the United States decreased during the early months of the COVID-19 pandemic in 2020, but most resurged by the end of that year.

Health News

‘Nothing for us without us’: achieving epidemic control among key populations in Africa

21 May 2022

While some countries in Africa are on the verge of reaching epidemic control – which means there are fewer HIV diagnoses than deaths of people with HIV – progress among key populations remains largely unknown, participants at the INTEREST 2022 conference in Kampala heard last week. In 2020, key populations and their sexual partners accounted for 39% of new HIV acquisitions in sub-Saharan Africa. However, only eight countries had prevalence data on people who inject drugs, while just two had data on transgender people. [...]

How do people feel after disclosing their HIV status on social media?

21 May 2022

Recent qualitative research with a small group of White gay and bisexual men in Australia found that they had chosen to talk about their HIV status on social media in order to control the narrative, challenge stigma and maintain a sense of agency. Instead of seeing it as responsibility to disclose, these men viewed it as a right to share their status. [...]

Women with HIV at greater risk of diabetes than men

21 May 2022

An analysis involving almost 40,000 people living with HIV in the United States has found that women are significantly more likely to be diagnosed with type 2 diabetes than both their male and HIV-negative counterparts. Dr Morgan Birabaharan and colleagues at the University of California analysed a huge observational patient record database that contained anonymised information from over 300 hospital sites in the US in order to establish a relationship between HIV, gender and type 2 diabetes. Findings are published in AIDS. [...]

Obesity more important than integrase inhibitors in risk for developing diabetes in people with HIV

21 May 2022

Obesity was the most important risk factor for developing diabetes in a large US HIV clinic cohort between 2008 and 2018, researchers from the University of Alabama at Birmingham report in a pre-print article released ahead of peer review this month. The study investigators say that preventing excess weight gain is critical for prevention of diabetes in people with HIV. [...]

NHS England is considering use of <i>Descovy</i> PrEP

21 May 2022

In a draft policy update, NHS England is proposing to reimburse the use of tenofovir alafenamide/emtricitabine (TAF/FTC), the combination pill sold as Descovy by its manufacturers Gilead Sciences, for 'second-line' PrEP. This would add an additional PrEP option as currently the only combination pill reimbursable for PrEP in England is tenofovir disoproxil fumarate/emtricitabine (TDF/FTC). [...]

Incident tuberculosis in one in three people starting antiretroviral therapy in Thailand

21 May 2022

A study from Thailand has found that the incidence of tuberculosis was remarkably high among people with HIV during the first year on antiretroviral therapy, and thereafter, decreased significantly until reaching levels comparable to those in the Thai general population after ten years. The study, published in a recent issue of the Journal of the International AIDS Society, is important as it is most probably the first to report such data from a high TB/HIV burden country in Asia. [...]

Botswana is ‘going for gold’ in eliminating vertical HIV transmission. Can the rest of Africa catch up?

21 May 2022

Botswana is testing almost all pregnant women for HIV when they register for antenatal care and retesting HIV-negative women on multiple occasions: every three months during pregnancy, at labour and delivery if there hasn’t been a recent test, six to eight weeks after birth, and every three months whilst breastfeeding. [...]

Here’s why oral PrEP in family planning services for young women in Kenya had dismal results

21 May 2022

A seven-month programme in Kenyan public hospitals to increase access and uptake of oral PrEP among adolescent girls and young women had low uptake, with critical challenges encountered in health facilities, the INTEREST 2022 conference in Kampala heard this week. The researchers make several recommendations for how uptake could be increased. [...]

Repeated infusions of two antibodies delay viral rebound but don’t prevent it

21 May 2022

Results from a new study show that receiving multiple doses of a combination of two broadly neutralising antibodies is safe, delays viral load rebound in the absence of antiretroviral therapy (ART), and may shrink the latent HIV reservoir. Out of 17 people who received multiple infusions of the two antibodies, 13 maintained viral suppression without ART for 20 weeks and some for longer. Two people maintained suppression for a year or more. [...]

COVID-19 pandemic restrictions did not harm HIV care outcomes in Uganda

21 May 2022

Despite the strict COVID-19 pandemic restrictions in Uganda, viral load testing and viral load suppression rates improved by 68% and 35% during the first lockdown, while mortality reduced by 25% among people living with HIV in the capital city, Kampala. These findings were reported yesterday by Dr Jonathan Izudi of Makerere University College of Health Sciences at the INTEREST 2022 conference, which is being held in Kampala. [...]

HEALTH A-Z

IMMUNOLOGY

Everything you need to know about cirrhosis

CANCER

What is seborrheic keratosis, moles, warts?

HIV

Integrase inhibitors give greater chance of viral suppression in pregnant women

Covid 19

CORONAVIRUS RESOURCE CENTER